Literature DB >> 32226183

[Hospital emergency plan for the management of patients with highly contagious diseases].

Petra Gastmeier1, M M Hoeper2, M Stoll3, H A Adams4.   

Abstract

Patients with imported highly contagious diseases like viral hemorrhagic fever (VHF), pneumonic plague or anthrax require special preventive measures and strict isolation. In addition, new emerging infections like severe acute respiratory syndrome (SARS) and epidemic influenza also have to be taken into account. At present five high security infectious disease units for patient care are available in Germany. Due to the relatively nonspecific symptoms, a patient with one of these infections may also be admitted to any other hospital. Therefore each hospital should develop a concept for the management and control of these lifethreatening highly contagious diseases. The present article describes the current emergency plan developed for the management of patients with highly contagious diseases at Hannover Medical School. © Steinkopff-Verlag 2007.

Entities:  

Keywords:  contagious diseases; emergency plan; infections

Year:  2007        PMID: 32226183      PMCID: PMC7098535          DOI: 10.1007/s00390-007-0782-x

Source DB:  PubMed          Journal:  Intensivmed Notfallmed        ISSN: 0175-3851


  3 in total

1.  The size distribution of droplets in the exhaled breath of healthy human subjects.

Authors:  R S Papineni; F S Rosenthal
Journal:  J Aerosol Med       Date:  1997

2.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

Review 3.  SARS in healthcare facilities, Toronto and Taiwan.

Authors:  L Clifford McDonald; Andrew E Simor; Ih-Jen Su; Susan Maloney; Marianna Ofner; Kow-Tong Chen; James F Lando; Allison McGeer; Min-Ling Lee; Daniel B Jernigan
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.